CLOV vs ORKA · rev $1.37B vs $4.27B cap
Clover Health Investments Corp (CLOV) versus Oruka Therapeutics, Inc. (ORKA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported ORKA revenue for 2024-06-30 was $0. Net income was -$22.2M. ORKA currently screens at market cap $4.27B.
CLOV currently screens at market cap $1.55B. ORKA currently screens at market cap $4.27B.
Not investment advice. Open the CLOV and ORKA stock pages for the full models.
Not investment advice.